New Ion AmpliSeq SARS-CoV-2 Research Panel, now optimized for the Ion Torrent Genexus System*, assists with contact tracing to identify coronavirus hot spots CARLSBAD, Calif. — As countries begin to ease restrictions and allow some businesses to reopen, contact tracing and epidemiological studies will be critical to understand resurgence of potential COVID-19 outbreaks. Scientists not only […]

Technology Advances Rapid, Cost-effective DNA Sequencing on Portable Devices SAN DIEGO, Calif. and LEUVEN, BELGIUM — Roswell Biotechnologies, Inc., the leader in molecular electronics sensor chips, and imec, a world-leading research and innovation hub in nanoelectronics and digital technologies,  announced today a partnership to develop the first commercially available molecular electronics biosensor chips. These chips are the brains […]

ST. LOUIS & AUGSBURG, Germany PierianDx, the leading clinical genomics informatics company, and University Hospital of Augsburg today announced a strategic development partnership to optimize an interpretation and reporting workflow based on the PierianDx Clinical Genomics Workspace™ platform for the AmpliSeq for Illumina Myeloid and Focus assays. Under the agreement, University Hospital of Augsburg will […]

Herlev, Denmark Today, Samplix launched its comprehensive service program to grant any laboratory access to the advantages of Xdrop™ technology. By partnering with the Samplix Service Team, researchers can leverage the unique Xdrop™ approach to address complex genomic questions, including gap closing, sequencing of repeat elements, detecting viral insertion sites, revealing unintended CRISPR edits, and […]

The Naica™ system, Stilla Technologies’ innovative digital PCR solution, combined with a Covid-19 detection kit, is able to quickly, accurately and reliably identify the SARS-CoV-2 virus, which is responsible for Covid-19, as well as measure its viral load. At the moment, the Naica system is mainly being used for research, and the company plans on expanding its use to diagnosis. Paris — Stilla Technologies, a leading French provider of pioneering solutions for high-precision genetic analyses, just announced that its […]

ANN ARBOR, Mich. — Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), announced the release of its Swift Amplicon SARS-CoV-2 Research Panel. Targeting the full viral genome in a single reaction with a rapid 2-hour workflow, Swift’s assay meets research and surveillance needs for standard samples […]

London, UK –  The UK genomic tools developer, RevoluGen Ltd., has appointed Sir John Chisholm as non-executive Chairman. Sir John was most recently Executive Chairman of Genomics England in which role he oversaw the world leading 100,000 Genome Project, which led to the UK being the first country to introduce Genomic Medicine into its health system. […]

SAN DIEGO — Illumina (NASDAQ: ILMN) today announced the appointment of Alex Aravanis as Chief Technology Officer. Dr. Aravanis will be responsible for leading Illumina’s research and technology development functions and the innovation engine for next-generation sequencing platforms and applications, accelerating technology breakthroughs and translation to the clinic. Dr. Aravanis will join Illumina in early […]

Collaboration focuses on developing multiplexed gene editing approaches using single-cell nano-manipulation technology that maintains cell viability and fitness. Boston & Zurich Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Cytosurge AG, a company manufacturing unique high-precision nanotechnology instruments, announced that they will collaboratively investigate CRISPR-based approaches to more effectively introduce multiple edits into the […]

NORCROSS, Ga.,– Omega Bio-tek announces collaboration with Ipsum Diagnostics in the fight against COVID-19. Omega Bio-tek will supply its Mag-Bind Viral DNA/RNA 96 Kit as a vital element in Ipsum Diagnostics’ approved RT-PCR-based SARS-CoV-2 assay.  The US Food and Drug Administration granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for RT-PCR-based SARS-CoV-2 testing on April […]